Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in...
Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving antic ancer vaccination strategies
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Toll-like receptor (TLR) agonists possess remarkable properties, particularly with regard to dendritic cell activation, promoting Th1-type cytokine production and optimizing cytotoxic T-cell responses. Preclinical and clinical studies conducted to date show that TLR agonists can improve currently applied anticancer vaccination protocols. Although t...
Alternative Titles
Full title
Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving antic ancer vaccination strategies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1399920525
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1399920525
Other Identifiers
ISSN
1750-743X
E-ISSN
1750-7448
DOI
10.2217/imt.13.24
